Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimers Disease Treatment
Year: 2012
Type: article
Source: Current Drug Targets
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: Alzheimer's disease, Lewy body disease, acetylcholinesterase inhibition, butyrylcholinesterase inhibition, monoamine oxidase A inhibition, monoamine oxidase B inhibition, neuroprotection, APP processing, protein kinase C signaling, MAPK signaling, oxidative stress, gliosis, global cerebral ischemia, closed head injury, cerebral edema, scopolamine-induced amnesia, antidepressant safety, neurotrophic factors, mitochondrial membrane potential
Open Access status: closed
OpenAlex ID: W1965718249
